v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities
The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets and liabilities were as follows (amounts in thousands):
Successor
December 31,
2022
December 31,
2021
Deferred tax assets
Tax loss carryforwards$73,097 $32,983 
Capitalized research and development15,624 8,734 
Research and development credits7,174 6,967 
Other1,467 1,016 
Total deferred tax assets$97,362 $49,700 
Valuation allowance(93,850)(49,045)
Deferred tax assets, net of allowance (*)
$3,512 $655 
(*) Included in Other non-current assets in the Consolidated Balance Sheets as of the respective periods.
Schedule of Income before Income Tax, Domestic and Foreign
Components of the Company’s pre-tax loss are as follows (amounts in thousands):

Successor
Twelve months ended December 31, 2022Period from January 30, 2021 through December 31, 2021
Loss before tax:
UK$(173,476)$(331,423)
Non-UK(43,478)(49,534)
Total $(216,954)$(380,957)
Schedule of Components of Income Tax Provision
The income tax (benefit) expense consists of the following (amounts in thousands):
Successor
December 31,
2022
December 31,
2021
Federal
Current$1,575 $581 
Deferred(2,464)(495)
State
Current534 188 
Deferred(392)(160)
Foreign
Current— — 
Deferred— — 
Income tax (benefit) expense$(747)$114 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the United Kingdom (“UK”) income tax rate to the Company’s effective tax rate is as follows:

Successor
Twelve Months Ended
December 31, 2022
Period from January 30, 2021 through
December 31, 2021
Statutory tax rate benefit19 %19 %
Non-deductible write-off of in-process R&D— %(11)%
Other non-deductible expenses(3)%(2)%
Enhanced research and development expenses%%
Losses surrendered for tax incentive(7)%(5)%
Non-taxable research and development incentive%%
Research & development tax credits%— %
Change in tax rate%%
Effect of overseas tax rates%%
Change in valuation allowance(23)%(8)%
Effective income tax rate— %— %
Summary of Operating Loss Carryforwards and Research Tax Credits
The following table summarizes carryforwards of federal and local net operating losses (NOL) and research tax credits (amounts in thousands):

Successor
December 31,
2022
December 31,
2021
UK$225,662 $82,156 
US$48,523 $34,059 
France$25,474 $19,710 
Germany$— $11,062